Literature DB >> 32210360

Base editing-mediated splicing correction therapy for spinal muscular atrophy.

Xiang Lin1,2, Haizhu Chen1, Ying-Qian Lu1, Shunyan Hong1, Xinde Hu3, Yanxia Gao3, Lu-Lu Lai1, Jin-Jing Li1, Zishuai Wang4, Wenqin Ying3, Lixiang Ma5, Ning Wang1,2, Erwei Zuo6, Hui Yang7, Wan-Jin Chen8,9.   

Abstract

Entities:  

Year:  2020        PMID: 32210360      PMCID: PMC7264321          DOI: 10.1038/s41422-020-0304-y

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  1 in total

1.  Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos.

Authors:  Erwei Zuo; Yidi Sun; Wu Wei; Tanglong Yuan; Wenqin Ying; Hao Sun; Liyun Yuan; Lars M Steinmetz; Yixue Li; Hui Yang
Journal:  Science       Date:  2019-02-28       Impact factor: 47.728

  1 in total
  13 in total

1.  Expanding the AtLAS of non-coding RNA functions in the brain.

Authors:  Matthew J Regier; Jason D Shepherd
Journal:  Cell Res       Date:  2020-04       Impact factor: 25.617

Review 2.  Advances in gene therapy for neurogenetic diseases: a brief review.

Authors:  Ying-Xuan Xie; Wen-Qi Lv; Yi-Kun Chen; Shunyan Hong; Xiang-Ping Yao; Wan-Jin Chen; Miao Zhao
Journal:  J Mol Med (Berl)       Date:  2021-11-27       Impact factor: 4.599

Review 3.  CRISPR Modeling and Correction of Cardiovascular Disease.

Authors:  Ning Liu; Eric N Olson
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 4.  Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges.

Authors:  Annarita Miccio; Panagiotis Antoniou; Sorana Ciura; Edor Kabashi
Journal:  Mol Ther       Date:  2021-04-03       Impact factor: 11.454

Review 5.  The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases.

Authors:  Sameh A Abdelnour; Long Xie; Abdallah A Hassanin; Erwei Zuo; Yangqing Lu
Journal:  Front Cell Dev Biol       Date:  2021-12-15

6.  High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells.

Authors:  Ju-Chan Park; Hyeon-Ki Jang; Jumee Kim; Jun Hee Han; Youngri Jung; Keuntae Kim; Sangsu Bae; Hyuk-Jin Cha
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

Review 7.  Primary Coenzyme Q10 Deficiency-7 and Pathogenic COQ4 Variants: Clinical Presentation, Biochemical Analyses, and Treatment.

Authors:  Jieqiong Xie; Jiayang Jiang; Qiwei Guo
Journal:  Front Genet       Date:  2022-01-26       Impact factor: 4.599

8.  Novel Intronic Mutations of TBK1 Promote Aberrant Splicing Modes in Amyotrophic Lateral Sclerosis.

Authors:  Ying-Qian Lu; Jian-Min Chen; Han Lin; Shu-Yan Feng; Chun-Hui Che; Chang-Yun Liu; Hua-Pin Huang; Zhang-Yu Zou
Journal:  Front Mol Neurosci       Date:  2022-02-24       Impact factor: 5.639

9.  Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia.

Authors:  Yi-Jun Chen; Zai-Qiang Zhang; Meng-Wen Wang; Yu-Sen Qiu; Ru-Ying Yuan; En-Lin Dong; Zhe Zhao; Hai-Tao Zhou; Ning Wang; Wan-Jin Chen; Xiang Lin
Journal:  Front Neurol       Date:  2021-05-19       Impact factor: 4.003

Review 10.  The Development and Application of a Base Editor in Biomedicine.

Authors:  Fang Wang; Yuqiang Zeng; Yi Wang; Yuyu Niu
Journal:  Biomed Res Int       Date:  2020-08-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.